Ratio of lathosterol to campesterol in serum predicts the cholesterol-lowering effect of sitostanol-supplemented margarine.

Thuluva, S. C.; Igel, M.; Giesa, U.; Lütjohann, D.; Sudhop, T.; von Bergmann, K.

Objective: Plant sterol/stanol margarines are recommended as a lipid-lowering dietary supplement in the treatment of hypercholesterolemia. Parameters predicting the individual cholesterol-lowering effect have not been elucidated so far. There fore, we investigated the responsiveness to sitostanol-supplemented margarine in a specially selected population. Methods and results: From a total number of 137 male subjects with hypercholesterolemia, eight subjects with the lowest and eight subjects with the highest ratios of lathosterol to campesterol in serum were included in the study. They received 1 g sitostanol-supplemented margarine b.i.d. for four weeks. Serum lipoproteins, the cholesterol precursor lathosterol, the plant sterols campesterol and sitosterol were measured. Subjects with a low ratio of lathosterol to campesterol had a significant decrease of serum total cholesterol (-14.2%; p <0.01) and LDL cholesterol (-13.8%; p < 0.01; responder). In subjects with a high ratio there was no significant change in total cholesterol and LDL cholesterol (2.2 and 4.3%; non-responder). Conclusion: The ratio of serum lathosterol to campesterol predicts the reduction of total cholesterol and LDL cholesterol during administration of sitostanol-supplemented margarine in patients with mild hypercholesterolemia.

MARGARINE; EDIBLE fats & oils; HYPERCHOLESTEREMIA; HYPERLIPIDEMIA; CLINICAL pharmacology; CLINICAL medicine; PHARMACOLOGY

International Journal of Clinical Pharmacology & Therapeutics, 2005, Vol 43, Issue 7, p305

0946-1965

Academic Journal

10.5414/CPP43305